SEZ6 and small cell lung carcinoma: In regard to thoracic oncology, studies have also previously demonstrated an overexpression of SEZ6 in SCLC and other high-grade neuroendocrine malignancies compared to that of normal tissues (with the CNS being the key exception) [72].